Novartis reports fiscal Q1 2026 results with non-GAAP EPS $1.99 (-13% YoY) and revenue $13.11B (-1% YoY), missing estimates
https://finviz.com/quote.ashx?t=NVS&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.